National Cancer Institute; Notice of Meeting, 26259-26260 [2014-10463]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 88 / Wednesday, May 7, 2014 / Notices
Services (HHS), Health Resources and
Services Administration (HRSA) (60 FR
56605, as amended November 6, 1995;
as last amended at Vol. 79, FR 18299–
18300 dated April 1, 2014).
This notice reflects organizational
changes to the Health Resources and
Services Administration. This notice
updates the functional statement for the
Office of Federal Assistance
Management (RJ), Division of Financial
Integrity (RJ1). Specifically, this notice
restructures the functions of the
Division of Financial Integrity (RJ1) to
serve as the focal point for resolving
audit findings and ensuring compliance
with program requirements.
Chapter RJ—Office of Federal
Assistance Management
Section RJ–20, Functions
Delete the functional statement for the
Division of Financial Integrity (RJ1), and
replace in its entirety.
Division of Financial Integrity (RJ1)
(1) Coordinates Agency-wide efforts
addressing HHS’s Program Integrity
Initiative; (2) serves as the Agency’s
focal point for resolving audit findings
on HRSA programs resulting from the
A–133 audits; (3) conducts financial
reviews of grantee’s use of HRSA funds;
(4) conducts the pre-award financial
assessment of HRSA grantees; (5)
conducts the pre-award and post-award
review of grant applicant’s and grantee’s
accounting systems; (6) conducts ad hoc
studies and reviews related to the
financial integrity of the HRSA business
processes related to assistance
programs; (7) conducts 340B program
audits of covered entities to ensure
program integrity and compliance with
340B program requirements; (8) serves
as the Agency’s liaison with the Office
of Inspector General for issues related to
grants; (9) coordinates the Agency’s
response to the HHS Office of Inspector
General Hotline complaints reporting
possible fraudulent fiscal activities
pertaining to HRSA grant funds; and
(10) establishes an assessment model for
grantee oversight.
pmangrum on DSK3VPTVN1PROD with NOTICES
Section RJ–30, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
VerDate Mar<15>2010
15:11 May 06, 2014
Jkt 232001
Dated: April 25, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014–10477 Filed 5–6–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meeting of the
National Cancer Advisory Board and
NCI Board of Scientific Advisors.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Advisory Board; ad Hoc Subcommittee on
Global Cancer Research.
Open: June 22, 2014, 6:15 p.m. to 7:45 p.m.
Agenda: Discussion on Global Cancer
Research.
Place: Hyatt Regency Bethesda, Cabinet
and Judiciary Rooms, One Bethesda Metro
Center, Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble,
Executive Secretary, NCAB ad Hoc
Subcommittee on Global Cancer Research,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W–562, Bethesda, MD 20892, (240) 276–
5796, trimblet@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board; Subcommittee on Budget
and Planning.
Open: June 22, 2014, 8:00 p.m. to 9:30 p.m.
Agenda: Discussion on Budget and
Planning.
Place: Hyatt Regency Bethesda, Cabinet
and Judiciary Rooms, One Bethesda Metro
Center, Bethesda, Maryland 20814.
Contact Person: Patrick O. McGarey,
Executive Secretary, NCAB Subcommittee on
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
26259
Budget and Planning, National Cancer
Institute, National Institutes of Health,
Building 31, 31 Center Drive, Room 11A16,
Bethesda, MD 20892, (301) 435–2612,
mcgareypo@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Open: June 23, 2014, 9:00 a.m. to 3:30 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board, and NCI Board of
Scientific Advisors; NCI Board of Scientific
Advisors Concepts Review, NCI Director’s
report, and presentations.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W–444,
Bethesda, MD 20892, (240) 276–6340.
Name of Committee: National Cancer
Advisory Board.
Closed: June 23, 2014, 3:30 p.m. to 5:00
p.m.
Agenda: Review of NCAB Grant
Applications.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W–444,
Bethesda, MD 20892, (240) 276–6340.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Open: June 24, 2014, 9:00 a.m. to 12:00
p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W–444,
Bethesda, MD 20892, (240) 276–6340.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: NCAB:
deainfo.nci.nih.gov/advisory/ncab.htm, BSA:
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
E:\FR\FM\07MYN1.SGM
07MYN1
26260
Federal Register / Vol. 79, No. 88 / Wednesday, May 7, 2014 / Notices
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS).
Dated: May 2, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
The meeting location has changed
from the National Institutes of Health to
the Hilton Washington DC/Rockville,
1750 Rockville Pike, MD 20852. The
meeting date and time remain the same.
The meeting is closed to the public.
Dated: May 1, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–10467 Filed 5–6–14; 8:45 am]
Dated: May 1, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2014–10464 Filed 5–6–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–10463 Filed 5–6–14; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Drug Abuse;
Notice of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Drug Abuse Special Emphasis Panel,
May 22, 2014, 12:00 p.m. to May 23,
2014, 05:00 p.m., National Institutes of
Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD
20852 which was published in the
Federal Register on April 28, 2014, 79
82 FR 2014–09616.
The date and time of the meeting were
changed to May 23, 2014, 1:00 p.m. to
May 23, 2014, 5:00 p.m. The meeting is
closed to the public.
Dated: May 1, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–10465 Filed 5–6–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pmangrum on DSK3VPTVN1PROD with NOTICES
National Center for Advancing
Translational Sciences; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Center for
Advancing Translational Sciences
Special Emphasis Panel, May 8, 2014,
08:00 a.m. to May 8, 2014, 12:30 p.m.,
National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 which
was published in the Federal Register
on April 8, 2014, 79 FR 19346 pg.
19346–19347.
VerDate Mar<15>2010
15:11 May 06, 2014
Jkt 232001
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, 301–
402–6020, hiromi.ono@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel NIDA I/
START Small Grant Review.
Date: June 4, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892–9550, 301–
435–1432, liangm@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIH
Pathway to Independence Award: PA–14–
042 (Parent K99/R00).
Date: June 25, 2014.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Amended Notice of
Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism, June 04, 2014, 05:00 p.m. to
June 05, 2014, 01:00 p.m. National
Institutes of Health, 5635 Fishers Lane,
Bethesda, MD, 20892 which was
published in the Federal Register on
March 14, 2014, 79 FR 14522.
The meeting notice is amended to
change the start time of June 5, 2014
meeting. The meeting will start at 8:15
a.m. and is closed to the public. The
meeting will open to the public at 9:00
a.m. The meeting is partially closed to
the public.
Dated: May 2, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–10476 Filed 5–6–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 79, Number 88 (Wednesday, May 7, 2014)]
[Notices]
[Pages 26259-26260]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10463]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the
National Cancer Advisory Board and NCI Board of Scientific Advisors.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
sections 552b(c)(4), and 552b(c)(6), Title 5 U.S.C., as amended. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board; ad Hoc
Subcommittee on Global Cancer Research.
Open: June 22, 2014, 6:15 p.m. to 7:45 p.m.
Agenda: Discussion on Global Cancer Research.
Place: Hyatt Regency Bethesda, Cabinet and Judiciary Rooms, One
Bethesda Metro Center, Bethesda, Maryland 20814.
Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB ad
Hoc Subcommittee on Global Cancer Research, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Room 3W-562, Bethesda, MD 20892, (240) 276-5796,
trimblet@mail.nih.gov.
Name of Committee: National Cancer Advisory Board; Subcommittee
on Budget and Planning.
Open: June 22, 2014, 8:00 p.m. to 9:30 p.m.
Agenda: Discussion on Budget and Planning.
Place: Hyatt Regency Bethesda, Cabinet and Judiciary Rooms, One
Bethesda Metro Center, Bethesda, Maryland 20814.
Contact Person: Patrick O. McGarey, Executive Secretary, NCAB
Subcommittee on Budget and Planning, National Cancer Institute,
National Institutes of Health, Building 31, 31 Center Drive, Room
11A16, Bethesda, MD 20892, (301) 435-2612, mcgareypo@mail.nih.gov.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Open: June 23, 2014, 9:00 a.m. to 3:30 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board, and
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors
Concepts Review, NCI Director's report, and presentations.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
Name of Committee: National Cancer Advisory Board.
Closed: June 23, 2014, 3:30 p.m. to 5:00 p.m.
Agenda: Review of NCAB Grant Applications.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Open: June 24, 2014, 9:00 a.m. to 12:00 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors.
Place: National Institutes of Health, 9000 Rockville Pike,
Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray, Executive Secretary,
National Cancer Institute, National Institutes of Health, 9606
Medical Center Drive, Room 7W-444, Bethesda, MD 20892, (240) 276-
6340.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: NCAB: deainfo.nci.nih.gov/advisory/ncab.htm, BSA:
deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
[[Page 26260]]
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS).
Dated: May 2, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-10463 Filed 5-6-14; 8:45 am]
BILLING CODE 4140-01-P
